ERBB2 and breast carcinoma: As 3D culture could better reflect HER signaling conditions and trastuzumab action in vivo, it will be employed in future studies to further assess the trastuzumab resistance mechanism in TSC2-MT and HER2-positive breast cancer cell lines.